| Amy Bissada, | |
|
629 N Chodikee Lake Rd, Highland, NY 12528-2726 | |
| (845) 691-6006 | |
| Not Available |
| Full Name | Amy Bissada |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Child & Adolescent Psychiatry |
| Location | 629 N Chodikee Lake Rd, Highland, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497041487 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0804X | Psychiatry & Neurology - Child & Adolescent Psychiatry | 279808 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Amy Bissada, 629 N Chodikee Lake Rd, Highland, NY 12528-2726 Ph: () - | Amy Bissada, 629 N Chodikee Lake Rd, Highland, NY 12528-2726 Ph: (845) 691-6006 |
News Archive
Every year, more than 11 million children die, six million of them from preventable diseases, like malaria, measles and diarrhoea. The UN Millennium Project, in its report to be released next week, outlines a plan to stop those children's deaths, cut poverty in half and change the lives of billions of poor people the world over by the year 2015.
Myriad Genetics, Inc. today announced the launch of PANEXIA™, a predictive medicine product for hereditary pancreatic and related cancers. PANEXIA is a comprehensive analysis of the PALB2 and BRCA2 genes for assessing a person's risk of developing pancreatic cancer later in life. PANEXIA, Myriad's ninth molecular diagnostic product, is the second product launched by the Company this year.
A team of scientists from the University of California San Francisco has identified distinct molecular markers that predict whether or not a woman is likely to develop subsequent invasive cancer after initial diagnosis with a noninvasive form of early breast cancer.
Santarus, Inc. and Depomed, Inc. today announced that they have entered into a new commercialization agreement for GLUMETZA (metformin hydrochloride extended release tablets) under which Santarus will assume broad commercial, manufacturing and regulatory responsibilities to replace a promotion agreement that the companies entered into in July 2008.
› Verified 7 days ago
Dr. Mary Bridgid Cruser, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1 Via Borgetto Rd, Highland, NY 12528 Phone: 845-235-2347 |